Skip to content
AdminMar 25, 2020< 1 min read

Empirical Assessment of Privacy Risks in Data

2020-03-05-Empirical-Assessment-of-Privacy-Risks-in-Data

Khaled El Emam, SVP & GM, Replica Analytics; Janice Branson, Global Head of Advanced Methodology & Data Science, Novartis; Nathan Good, Principal, Good Research

Presentation on our experiences with trying to identify individuals in datasets that have been de-personalized, especially health data. This is an overview of Motivated Intruder Attacks.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

AdminMay 6, 20241 min read

Navigating the European Union's Medical Device Regulation (MDR)

On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became effective. The MDR overhauls how the EU ...
Start Reading
Xi FangApr 20, 20241 min read

How to unleash the replicability potential of synthetic data

In today's data-driven world, the need for innovative solutions to evolve alongside the ever-challenging landscape of privacy ...
Start Reading
AdminApr 19, 2024< 1 min read

Case Study: Enhancing clinical trial data sharing with synthetic datasets

Unlock the future of research with our groundbreaking approach to privacy-preserving data sharing. Our case study, "Enhancing ...
Start Reading